ESPR - CIK 0001434868
The table below shows Esperion Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $167.85M | $144.76M | $82.25M | $124.78M | $208.89M | $304.96M |
| Short-term investments | - | - | $0.00 | $42.09M | $50.44M | - |
| Receivables | $140.19M | $80.14M | $48.49M | $33.73M | $22.93M | - |
| Inventory | $105.12M | $94.49M | $65.62M | $35.20M | $34.39M | $16.14M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $462.57M |
| $338.00M |
| $201.06M |
| $246.68M |
| $328.97M |
| $345.90M |
| Property, plant & equipment | $338.00K | $254.00K | $0.00 | $164.00K | $664.00K | $1.28M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $465.89M | $343.82M | $205.80M | $247.94M | $381.59M | $353.26M |
| Accounts payable | $65.07M | $51.65M | $31.72M | $23.04M | $17.56M | $51.98M |
| Total current liabilities | $300.81M | $246.23M | $156.22M | $92.31M | $73.35M | $94.07M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $767.85M | $732.54M | $660.79M | $571.72M | $578.53M | $449.39M |
| Retained earnings | -$1.62B | -$1.60B | -$1.55B | -$1.34B | -$1.11B | -$838.82M |
| Total equity | -$301.96M | -$388.72M | -$454.99M | -$323.78M | -$196.94M | -$96.13M |